Menu Search
Equities

CompuMed Inc

CMPD:PKC

CompuMed Inc

Actions
  • Price (USD)3.70
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change+72.09%
  • Beta0.2467
Data delayed at least 15 minutes, as of Sep 20 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year CompuMed Inc had revenues remain flat at 1.68m, though the company grew net income from a loss of 223.00k to a smaller loss of 70.00k. A reduction in the selling, general and administrative costs as a percentage of sales from 63.95% to 54.66% was a component in the net income growth despite flat revenues.
Gross margin50.42%
Net profit margin-8.38%
Operating margin-7.09%
Return on assets-19.92%
Return on equity-143.13%
Return on investment-48.38%
More ▼

Cash flow in USDView more

In 2012, cash reserves at CompuMed Inc fell by 45.00k. However, the company earned 42.00k from its operations for a Cash Flow Margin of 2.54%. In addition the company used 25.00k on investing activities and also paid 62.00k in financing cash flows.
Cash flow per share-0.0532
Price/Cash flow per share--
Book value per share0.0997
Tangible book value per share0.0036
More ▼

Balance sheet in USDView more

CompuMed Inc has a Debt to Total Capital ratio of 77.44%, a lower figure than the previous year's 104.90%.
Current ratio0.9919
Quick ratio0.9493
Total debt/total equity3.43
Total debt/total capital0.7744
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.